Bridging Experience and New Frontiers in Left Ventricular Assist Device Therapy in Japan ― Insights From the J-MACS Report ―
Year: 2026
Type: article
Abstract: tality rates >40%. 1 Intravenous inotropes and durable left ventricular assist devices (LVAD) as bridge-to-transplan-D espite advancements in both medical treatment and interventional therapeutics for heart failure (HF), many patients still progress into an advanced phase.The prognosis of medically treated patients with advanced HF remains poor, with 1-year mor-Article p ????The opinions expressed in this article are not necessarily those of the editors or of the Japanese Circulation Society.
Source: Circulation Journal
Authors: Toru Hashimoto, Kohtaro Abe
Institution: Kyushu University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7223235432